![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 20, 17559-17567, May 18, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
§,
§,
§,
§,
§
From the pRB family pocket proteins consisting of pRB,
p107, and p130 are thought to act as a set of growth regulators that
inhibit the cell cycle transition from G1 to S phases
by virtue of their interaction with E2F transcription factors. When
cells are committed to progressing through the cell cycle at the late
G1 restriction point, they are hyperphosphorylated by
G1 cyclin-cyclin-dependent kinase and
are functionally inactivated. Consistent with such a G1
regulatory role, pRB and p130 are abundantly expressed in quiescent
cells. In contrast, p107 is present at low levels in the
hypophosphorylated form in quiescent cells. As cells progress toward
late G1 to S phases, the levels of p107 increase, and the majority become hyperphosphorylated, suggesting a possible role of p107
in post-G1 cell cycle regulation. In this study, we have demonstrated that a nonphosphorylatable and thus constitutively active
p107 has the potential to inhibit S phase progression. The levels of
the phosphorylation-resistant p107 required for the S phase inhibition
are significantly less than those of endogenous p107. We further show
herein that the exposure of cells to the DNA-damaging agent, cisplatin,
provokes S phase arrest, which is concomitantly associated with the
accumulation of hypophosphorylated p107. Furthermore, the S phase
inhibitory response to cisplatin is augmented by the ectopic expression
of wild type p107, although it is diminished by the adenovirus E1A
oncoprotein, which counteracts the pocket protein functions.
Because p107 is a major pRB family protein expressed in S phase cells,
our results indicate that p107 participates in an inhibition of cell
cycle progression in response to DNA damage in S phase cells.
Division of Molecular Oncology, Institute
for Genetic Medicine, ¶ Department of Medicine II, School of
Medicine, Hokkaido University, Kita-ku, Sapporo 060, and the
§ Department of Viral Oncology, Cancer Institute, Japanese
Foundation for Cancer Research, Toshima-ku, Tokyo 170, Japan
To whom correspondence should be addressed: Div. of Molecular
Oncology, Inst. for Genetic Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo 060-0815, Japan. Tel./Fax:
81-11-709-6482; E-mail: mhata@imm.hokudai.ac.jp.
This article has been cited by other articles:
![]() |
T. E. Lyons, M. Salih, and B. S. Tuana Activating E2Fs mediate transcriptional regulation of human E2F6 repressor Am J Physiol Cell Physiol, January 1, 2006; 290(1): C189 - C199. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. White, E. Stead, R. Faast, S. Conn, P. Cartwright, and S. Dalton Developmental Activation of the Rb-E2F Pathway and Establishment of Cell Cycle-regulated Cyclin-dependent Kinase Activity during Embryonic Stem Cell Differentiation Mol. Biol. Cell, April 1, 2005; 16(4): 2018 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takebayashi, H. Higashi, H. Sudo, H. Ozawa, E. Suzuki, O. Shirado, H. Katoh, and M. Hatakeyama NF-kappa B-dependent Induction of Cyclin D1 by Retinoblastoma Protein (pRB) Family Proteins and Tumor-derived pRB Mutants J. Biol. Chem., April 18, 2003; 278(17): 14897 - 14905. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Laplantine, F. Rossi, M. Sahni, C. Basilico, and D. Cobrinik FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest J. Cell Biol., August 19, 2002; 158(4): 741 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Agrawal, M. L. Agarwal, M. Chatterjee-Kishore, G. R. Stark, and G. M. Chisolm Stat1-Dependent, p53-Independent Expression of p21waf1 Modulates Oxysterol-Induced Apoptosis Mol. Cell. Biol., April 1, 2002; 22(7): 1981 - 1992. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |